Replies to post #1569 on GG&G

[2Relax]

Just a reminder, don’t forget to factor these two critical elements into your formula’s.

1) How many ActiPatches does the avg user wear?

2) how many times do they repurchase?

These two will greatly increase numbers. Here’s an example:

26M chronic users (UK Wales)
5% market penetration (1.3M people):

i.e.:

(1) unit per person 4 repurchases
Simple math - 1.3M people x 1 unit worn at a time x repurchased (4) times x $11 (estimate lowest price to NHS pharmacies)
1.3M x 1 x 4 x $11 = $57.2M


(2) units per person 3 repurchases
Simple math - 1.3M people x 2 units worn at a time x repurchased (3) times x $11 (estimate lowest price to NHS pharmacies)
1.3M x 2 x 3 x $11 = $85.8M

I’m working on table charts as examples. Everyone can see an adjust for themselves. It’s crazy how high the biggest number I come up with is when I figure a 33% market penetration when it has finally been accepted and known around the globe. And this isn’t just for chronic pains users. Other household members will be using them for typical everyday injuries; Cuts bruises falls inflammation headaches etc. as people become comfortable with the dozens of others uses for typical injuries, they will be repurchased more often IMO. This works great on every injury our family has tried them on. The only differences we’ve found was the severity of the injury and the individual person.